NL-OMON41752已完成不适用
An open-label, single-dose study to assess the relative bioavailability of 2 new formulations of UCB5857 versus the reference formulation, and to evaluate the mass balance recovery and the absolute bioavailability of UCB5857 using intravenous and oral microtracers in healthy subjects - UCB5857 mass balance and absolute bioavailability study
CB Celltech0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy subjects
- •18 - 55 yrs, inclusive
- •BMI : 18.0 - 30.0 kg/m2, inclusive
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
进行中（未招募）
不适用
Study to evaluate the response and efficiency of the study medication Cinryze for treatment of acute angiodema attacks (Quincke-oedema) in children less than 12 years of age with hereditary angiooedema.EUCTR2011-000369-11-DEViroPharma Incorporated12
招募中
1 期
An Open-label, Single-Dose Study to Investigate the Pharmacokinetics of KSP-1007 in Healthy Adult Chinese SubjectsHospital-acquired pneumonia including ventilator-associated pneumoniaJPRN-jRCT2071230099Tsukada Hironobu32
已完成
不适用
An open-label and single-dosing study to evaluate the safety, pharmacokinetics and food effect of UI026 in healthy male volunteers.KCT0003451Chungnam National University Hospital12
未知
1 期
An open-label, single-dose study to evaluate the pharmacokinetics and safety of DS-8500a in Japanese subjects with varying degrees of hepatic or renal functioSubjects with hepatic or renal impairmentJPRN-jRCT2080223081DAIICHI SANKYO CO., LTD.48
招募中
1 期
A single-arm, open-label study to evaluate the efficacy and safety of ABBV-668 in subjectswith moderate to severe ulcerative colitislcerative ColitisMedDRA version: 20.0Level: PTClassification code: 10009900Term: Colitis ulcerative Class: 100000004856CTIS2022-501263-41-00Abbvie Deutschland GmbH & Co. KG60